Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

UK clears first use of e-consent tech in clinical trial

A drugmaker trialling an autoimmune disease treatment in the UK has become the first cleared to use electronic informed consent by the National Health Service (NHS).

The USDA said a goat and rabbits were mistreated at Santa Cruz Biotechnology

Hepalink adding biologics CDMO Cytovance in $200m acquisition

API supplier Hepalink will buy Cytovance for $206m (€183m) in a deal the biologics CDMO says will help expedite its expansion plans.

Shire to use new suppliers to up production of HAE drug filtered from US plasma

Shire will use contractors to increase production of Cinryze, the half billion dollar-a-year Hereditary Angioedema (HAE) drug it bought with ViroPharma in 2014.   


The week in outsourcing appointments

A CEO for Halo, plus senior appointments at INC Research, Unilife and Certara.

Mid-sized M&A madness: Smaller deals dominate CRO space so far in 2015

Chiltern’s takeover of Theorem Clinical will be the latest acquisition in a busy eight months of deals impacting the mid-sized CRO space.

Recipharm to make 3-API drug for Israel’s RedHill

Swedish CDMO Recipharm will contract manufacture a three-drug combination antibiotic for emerging Israeli biopharma RedHill.

Merck KGaA closes Indian bio supplies subsidiary

Merck Millipore says it has closed the Bangalore plant which produced its GeNei brand of biologics manufacturing and R&D supplies.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...